Cargando…
The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion
BACKGROUND: Malignant pleural effusion (MPE) is a condition, that can be seen in 15% of patients diagnosed with cancer. Because of the short overall survival, it is important to identify the appropriate treatment. In addition to the palliation of secondary symptoms due to MPE, it should also be deci...
Autores principales: | Ermin, Sinem, Özdoğan, Yasemin, Batum, Özgür, Yılmaz, Ufuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390290/ https://www.ncbi.nlm.nih.gov/pubmed/35848663 http://dx.doi.org/10.4103/lungindia.lungindia_633_21 |
Ejemplares similares
-
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014) -
Does the LENT score risk‐stratify patients with malignant pleural mesothelioma? An observational study
por: Chollet, Bertrand, et al.
Publicado: (2021) -
Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion
por: Zhang, Tianli, et al.
Publicado: (2021) -
A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis
por: Cobanoglu, Ufuk, et al.
Publicado: (2018) -
Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score
por: Chantharakhit, Chaichana, et al.
Publicado: (2022)